AngioDynamics, Inc. (ANGO) Financials

ANGO Assets vs Liabilities

DateAssetsLiabilities
2024-02-29 323.6 million 107.6 million
2023-11-30 499.6 million 98.4 million
2023-08-31 493.9 million 66.1 million
2023-05-31 532.6 million 154.3 million

ANGO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-02-29 -13.1 million 2.6 million
2023-11-30 4.7 million 1.9 million
2023-08-31 -26.7 million 4.1 million
2023-05-31 14.9 million 3.0 million

ANGO Net Income

No data available :(

ANGO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-02-29 78.5 million - -
2023-11-30 60.9 million - -
2023-08-31 57.6 million - -
2023-05-31 44.6 million 49.8 million -

ANGO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-02-29 40.2 million
2023-11-30 40.2 million
2023-08-31 40.0 million
2023-05-31 39.6 million

ANGO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-02-29 607000 8.2 million 10.6 million 25.4 million
2023-11-30 554000 8.7 million 9.3 million 25.5 million
2023-08-31 791000 7.9 million 10.9 million 27.4 million
2023-05-31 1.1 million 7.9 million 10.2 million 26.3 million

ANGO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-02-29 75.2 million 42.6 million
2023-11-30 79.1 million 38.8 million
2023-08-31 78.7 million 38.6 million
2023-05-31 91.1 million 44.7 million

ANGO

Price: $6.27

52 week price:
5.26
11.38

Payout Ratio Range:
-5.28%
52.27%

Earnings Per Share: -0.36 USD

P/E Ratio: -17.08

Exchange: NMS

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 233107

Ebitda: 7.0 million

Market Capitalization: 277.8 million

Links: